G

ood morning, everyone, and welcome to the middle of the week. You made it this far, so why not carry on? Our survival plan calls for quaffing a cup or three of delicious stimulation. Our choice today is wild mountain blueberry. As always, you are welcome to join us. Remember — no prescription is required. So time to get cracking. After all, there are meetings, phone calls, and deadlines awaiting. To help you along, we have gathered a menu of tidbits. We hope you find them helpful. Meanwhile, have a wonderful day and do stay in touch …

The Medicines Company (MDCO) plans to restructure and lay off more than 85 percent of its workforce, MarketWatch tells us. The drug maker, which currently has 410 employees, plans to reduce headcount to fewer than 60 people and carry out most of the restructuring in the next 45 days. The company plans to announce a divestiture of its infectious diseases business by the end of the year.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy